Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats

Toxicology and Applied Pharmacology

Volumn 219, Issue 1, 2007, Pages 10-17

  Tang, Lili ^a,b   Guan, Hongxia ^a   Ding, Xiaolin ^b   Wang, Jia Sheng ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

8 Hydroxydeoxyguanosine; AFB1 biomarkers; Aflatoxin B1; Lycopene; Metabolic activation; Phase 1 and 2 metabolism

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; AFLATOXIN; AFLATOXIN B1; AFLATOXIN M1; AFLATOXIN P1; AFLATOXIN Q1; ALBUMIN; BIOLOGICAL MARKER; CORN OIL; GUANINE DERIVATIVE; LYCOPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; ENZYME ACTIVITY; ENZYME INDUCTION; MALE; METABOLIC INHIBITION; METABOLIC REGULATION; METABOLITE; MULTIPLE CYCLE TREATMENT; NONHUMAN; RAT; URINARY EXCRETION;

AFLATOXIN B1; ALBUMINS; ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL MARKERS; CARCINOGENS; CAROTENOIDS; DEOXYGUANOSINE; DNA; HYDROLYSIS; LIVER; MALE; RATS; RATS, INBRED F344;

ANIMALIA; RATTUS; ZEA MAYS;

EID: 33846862928     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.12.001     Document Type: Article

References (56)

1. Astorg P., Gradelet S., Berges R., and Suschetet M. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr. Cancer 29 (1997) 60-68
2. Azziz-Baumgartner E., Lindblade K., Gieseker K., Rogers H.S., Kieszak S., Njapau H., Schleicher R., McCoy L.F., Misore A., DeCock K., Rubin C., and Slutsker L. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health Perspect. 113 (2005) 1779-1783
3. Bhuvaneswari V., Velmurugan B., Balasenthil S., Ramachandran C.R., and Nagini S. Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Fitoterapia 72 (2001) 865-874
4. Breinholt V., Lauridsen S.T., Daneshvar B., and Jakobsen J. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 154 (2000) 201-210
5. Busby Jr. W.F., and Wogan G.N. Aflatoxins (1984), American Chemical Society, Washington, DC
6. Chen L., Stacewicz-Sapuntzakis M., Duncan C., Sharifi R., Ghosh L., van Breemen R., Ashton D., and Bowen P.E. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93 (2001) 1872-1879
7. Clinton S.K. Lycopene: chemistry, biology, and implications for human health and disease. Nutr. Rev. 56 (1998) 35-51
8. Eaton D.L., and Gallagher E.P. Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 135-172
9. 1 in vitro. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 1870-1874
10. Gange S.J., Munoz A., Wang J.S., and Groopman J.D. Variability of molecular biomarker measurements from nonlinear calibration curves. Cancer Epidemiol., Biomarkers Prev. 5 (1996) 57-61
11. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer. Inst. 91 (1999) 317-331
12. 1 metabolism. Carcinogenesis 19 (1998) 403-411
13. Groopman J.D. DNA adducts of nitropyrene detected by specific antibodies. Res. Rep.-Health Eff. Inst. (1987) 1-17
14. Groopman J.D., and Kensler T.W. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?. Carcinogenesis 20 (1999) 1-11
15. 1-adducted DNA. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 5445-5449
16. 7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Carcinogenesis 13 (1992) 101-106
17. 7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Res. 52 (1992) 267-274
18. Groopman J.D., Roebuck B.D., and Kensler T.W. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Prog. Clin. Biol. Res. 374 (1992) 139-155
19. 7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ. Health Perspect. 99 (1993) 107-113
20. Heber D., and Lu Q.Y. Overview of mechanisms of action of lycopene. Exp. Biol. Med. (Maywood) 227 (2002) 920-923
21. 1 in rats: effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study. Toxicol. Sci. 73 (2003) 362-377
22. IARC. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins (1993), IARC Press, Lyon {Busby, 1984 #652}
23. IARC. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene (2002), IARC Press, Lyon
24. 1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 17 (2005) 807-814
25. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 46 (1986) 3924-3931
26. Kensler T., Styczynski P., Groopman J., Helzlsouer K., Curphey T., Maxuitenko Y., and Roebuck B.D. Mechanisms of chemoprotection by oltipraz. J. Cell. Biochem., Suppl. 16I (1992) 167-172
27. Kensler T.W., Groopman J.D., Sutter T.R., Curphey T.J., and Roebuck B.D. Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol. 12 (1999) 113-126
28. Klein E.A., and Thompson I.M. Update on chemoprevention of prostate cancer. Curr. Opin. Urol. 14 (2004) 143-149
29. Kwak M.K., Egner P.A., Dolan P.M., Ramos-Gomez M., Groopman J.D., Itoh K., Yamamoto M., and Kensler T.W. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480-481 (2001) 305-315
30. Lee A., Thurnham D.I., and Chopra M. Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma. Free Radical Biol. Med. 29 (2000) 1051-1055
31. Lewis L., Onsongo M., Njapau H., Schurz-Rogers H., Luber G., Kieszak S., Nyamongo J., Backer L., Dahiye A.M., Misore A., DeCock K., and Rubin C. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environ. Health Perspect. 113 (2005) 1763-1767
32. Matos H.R., Di Mascio P., and Medeiros M.H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch. Biochem. Biophys. 383 (2000) 56-59
33. Matos H.R., Capelozzi V.L., Gomes O.F., Mascio P.D., and Medeiros M.H. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate. Arch. Biochem. Biophys. 396 (2001) 171-177
34. Matulka R.A., Hood A.M., and Griffiths J.C. Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes. Regul. Toxicol. Pharmacol. 39 (2004) 390-402
35. McCullough M.L., and Giovannucci E.L. Diet and cancer prevention. Oncogene 23 (2004) 6349-6364
36. Nagasawa H., Mitamura T., Sakamoto S., and Yamamoto K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 15 (1995) 1173-1178
37. Paetau I., Khachik F., Brown E.D., Beecher G.R., Kramer T.R., Chittams J., and Clevidence B.A. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am. J. Clin. Nutr. 68 (1998) 1187-1195
38. Rehman A., Bourne L.C., Halliwell B., and Rice-Evans C.A. Tomato consumption modulates oxidative DNA damage in humans. Biochem. Biophys. Res. Commun. 262 (1999) 828-831
39. 1 in vivo in rats. Carcinogenesis 8 (1987) 819-824
40. l excretion in rat urine during dietary intervention with oltipraz. Carcinogenesis 17 (1996) 1385-1388
41. 1 mercapturic acids and their identification in rat urine. Chem. Res. Toxicol. 10 (1997) 1144-1151
42. 1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 16 (1995) 419-422
43. 1. Free Radical Biol. Med. 21 (1996) 139-146
44. Shigenaga M.K., Gimeno C.J., and Ames B.N. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9697-9701
45. Steinmetz K.A., and Potter J.D. Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 96 (1996) 1027-1039
46. Tang L., Jin T., Zeng X., and Wang J.S. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 135 (2005) 287-290
47. Turner P.C., Moore S.E., Hall A.J., Prentice A.M., and Wild C.P. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111 (2003) 217-220
48. Vaishampayan U., Fontana J., Du W., and Hussain M. Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma. Am. J. Clin. Oncol. 27 (2004) 550-554
49. Velmurugan B., Bhuvaneswari V., Burra U.K., and Nagini S. Prevention of N-methyl-N′-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. Eur. J. Cancer Prev. 11 (2002) 19-26
50. Wang J.S., and Groopman J.D. DNA damage by mycotoxins. Mutat. Res. 424 (1999) 167-181
51. Wang J.S., Qian G.S., Zarba A., He X., Zhu Y.R., Zhang B.C., Jacobson L., Gange S.J., Munoz A., Kensler T.W., et al. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol., Biomarkers Prev. 5 (1996) 253-261
52. 1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst. 91 (1999) 347-354
53. Wertz K., Siler U., and Goralczyk R. Lycopene: modes of action to promote prostate health. Arch. Biochem. Biophys. 430 (2004) 127-134
54. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313 Pt. 1 (1996) 17-29
55. Wogan G.N. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52 (1992) 2114s-2118s
56. Xu Y., Leo M.A., and Lieber C.S. Lycopene attenuates arachidonic acid toxicity in HepG2 cells overexpressing CYP2E1. Biochem. Biophys. Res. Commun. 303 (2003) 745-750